Innoplexus proudly announces the launch of its product iPlexusTM, at Bio-IT World, 2017,Booth #355.It is an end to end platform for Life Sciences which leverages Artificial Intelligence(AI) to generate continuous intelligence and insights, across discovery, clinical development, regulatory and commercial stages of drug development, spanning all major therapeutic areas and indications.
In many organizations, Decision making is still a batch process.
Data – Requires human effort and is expensive
Traditionally, both generation and consumption of intelligence and insights in enterprises remain predominantly manual.
Manually curated & analyzed data in presentations, lack real-time insights and are not comprehensive, rendering decision making a batch process.
We’re helping organizations move to continuous decision making by generating insights from structured and unstructured private and public data by using proprietary algorithms, machine learning & AI.